HilleVax OverviewHilleVax EBIT
EBIT (Earnings Before Interest and Taxes) analysis for HLVX.
Quarterly EBIT
-$5.27M
↑ 84.84% YoY
As of Jun 30, 2025
Annual EBIT (TTM)
-$73.69M
↑ 48.85% YoY
Trailing 12 months ending Jun 30, 2025
HilleVax OverviewEBIT (Earnings Before Interest and Taxes) analysis for HLVX.
As of Jun 30, 2025
Trailing 12 months ending Jun 30, 2025